Orca Pharmaceuticals GDPR Commitment Statement

The General Data Protection Regulation (GDPR) is the latest EU data privacy and protection framework, which is effective from 25th May 2018.

Orca Pharmaceuticals Ltd is a company based in Oxford UK developing oral drugs for the treatment of chronic inflammatory disease. Whilst we process very little Personal Data, we are committed to ensuring that it is collected, processed, stored and disposed of in line with GDPR standards.

We are committed to GDPR compliance including building GDPR into our current and future processes and contractual commitments.